| Name | Title | Contact Details |
|---|---|---|
Daniel Chen |
VP of Technology and Solution Architect | Profile |
Public Risk Innovation, Solutions, and Management, PRISM, is a member-directed risk sharing pool of counties and public entities committed to providing risk coverage programs and risk management services.
The impact of disasters—natural or otherwise—can leave even the most robust entities vulnerable, causing uncertainty over their future. This constant threat magnifies stress, strains resources, and hampers growth, making resilience more crucial than ever. At Tidal Basin Group, we tackle these challenges head-on. As architects of resilience, we transform vulnerability into strength through innovative thinking and integrated solutions in program management, technology and emergency consulting. We listen, consider diverse perspectives, and equip you with the tools to redefine resilience. Our mission is to empower organizations and communities to rebound from challenges, and create a future where resilience is the backbone of every strategy—helping everyone to Be stronger than before®.
Smartchoice.pk is Pakistans leading insurance marketplace. We have helped thousands of individuals and business find best insurance plans. We work with Pakistans top insurance companies including EFU, Jubilee, Adamjee, IGI, TPL, UIC Pak Qatar Genreral Takaful offering customised plans for business and individuals to instantly purchase policy online For Business: Group Health Insurance Group Life Insurance For Individuals Travel Insurance* Health Insurance* Car Insurance Term Life Insurance Personal Accident Insurance *Pay online and get insured instantly. We have been covered by Dawn, British Council UK, Tribune, Insurance Post UK
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Everwise Credit Union puts peoples needs first, so no matter your story or your money savvy, we meet you where you are and equip you with the confidence and tools you need to get ahead—wherever youre going. Originally founded as Teachers Credit Union, helping people understand and manage their financial future has always been central to what we do, even as weve expanded our community beyond teachers. Today, we serve more than 300,000 members across nearly 60 locations in the heart of the Midwest. Through personalized resources, services, tools and unparalleled access to innovative technology, we help everyone—teenagers to retirees, business leaders to the under-served—feel more in control of their money and their future. With every interaction, we seek to fulfill our purpose of helping people grow into their dreams. ©2023 Everwise Credit Union | NMLS #686706 | Federally Insured by NCUA | Equal Housing Opportunity